| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000047711 |
| Receipt No. | R000054391 |
| Scientific Title | Effects of Antimicrobial Peptides Application after Non-surgical Periodontal Therapy on Treatment of Stage III and Grade B Periodontitis: A Randomized Clinical and Microbiological Trial |
| Date of disclosure of the study information | 2022/06/01 |
| Last modified on | 2022/05/10 (Ver. 2) |
| Basic information | ||
| Public title | Effects of Antimicrobial Peptides Application after Non-surgical Periodontal Therapy on Treatment of Stage III and Grade B Periodontitis: A Randomized Clinical and Microbiological Trial | |
| Acronym | AMPs | |
| Scientific Title | Effects of Antimicrobial Peptides Application after Non-surgical Periodontal Therapy on Treatment of Stage III and Grade B Periodontitis: A Randomized Clinical and Microbiological Trial | |
| Scientific Title:Acronym | AMPs | |
| Region |
|
|
| Condition | ||||||
| Condition | In this randomized clinical trial, we aimed to evaluate the effects of AMPs as an addition to SRP on clinical parameters and microbiological biofilms in patients with Stage III and Grade B periodontitis. | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | To evaluate the effects of the antimicrobial peptides (AMPs) as an adjunct to scaling and root planning (SRP) on clinical and microbiological outcomes in patients with periodontitis in Stage III and Grade B. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | probing depth,clinical attachment level,Bleeding index, and Microbiological results |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Dose comparison |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as a block. |
| Blocking | NO |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | SRP with AMPs group (AMP group)/SRP group | |
| Interventions/Control_2 | SRP with AMPs group (AMP group)/SRP with minocycline hydrochloride group (Perio group) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The inclusion criteria were: (1) at least 20 years old, (2) previously untreated Stage III and Grade B periodontitis by clinically and radiologically17, (3) a minimum of 20 natural teeth in the mouth, and more than 4 molars. | |||
| Key exclusion criteria | The exclusion criteria were: (1) acute oral lesions or necrotizing ulcerative periodontitis, (2) having received antibiotics within 6 months or the need for antibiotic coverage during experiment, (3) being allergic to minocycline, (4) no orthodontic treatment, (5) a history of systemic diseases, (6) pregnancy, (7) smoker | |||
| Target sample size | 51 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | School of Stomatology, Capital Medical University | ||||||
| Division name | CCMU | ||||||
| Zip code | 100050 | ||||||
| Address | Tian Tan Xi Li No.4 | ||||||
| TEL | 86-10-57099450 | ||||||
| qhddenver@126.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Beijing Stomatological Hospital, Capital Medical University | ||||||
| Division name | CCMU | ||||||
| Zip code | 100050 | ||||||
| Address | Tian Tan Xi Li No.4 | ||||||
| TEL | 86-10-57099450 | ||||||
| Homepage URL | |||||||
| morose2012@sina.cn | |||||||
| Sponsor | |
| Institute | Department of Periodontics,Beijing Stomatological Hospital, Capital Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Nature Science Foundation of China, the Discipline Construction Fund of Beijing Stomatological Hospital, Beijing Stomatological Hospital, Capital Medical University Young Scientist Program . |
| Organization | |
| Division | |
| Category of Funding Organization | Outside Japan |
| Nationality of Funding Organization | China |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Beijing Stomatological Hospital, Capital Medical University |
| Address | Tian Tan Xi Li No.4 |
| Tel | 86-10-57099450 |
| morose2012@sina.cn | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | Beijing Stomatological Hospital, Capital Medical University |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://wiley.atyponrex.com/dashboard |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | https://wiley.atyponrex.com/dashboard | ||||||
| Number of participants that the trial has enrolled | 51 | ||||||
| Results | Probing depth:the reduction was significantly higher in the AMP group than in the other two groups (p<0.001).
Attachment level and Bleeding index: The AMP group at 90 days not only showed an increase in attachment gain and reduction in the bleeding index compared with the baseline of this group but also showed a significantly higher increase than the other two groups (p< 0.05). |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | patients with Stage III and Grade B Periodontitis | ||||||
| Participant flow | https://wiley.atyponrex.com/dashboard | ||||||
| Adverse events | no | ||||||
| Outcome measures | https://wiley.atyponrex.com/dashboard | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054391 |